Holzer & Holzer, LLC is investigating whether Merge Healthcare, Incorporated ("Merge" or the "Company") (NASDAQ: MRGE) and/or certain of its officers complied with the federal securities laws when making statements to investors between February 19, 2013 and January 8, 2014. Specifically, the investigation focuses on statements issued by Merge during that time regarding, among other things, its financial condition and its internal controls. On January 8, 2014, Merge announced that it was "reducing its previously-announced non-GAAP subscription backlog totals for the Merge DNA segment for the quarterly periods ended June 30, 2012 through September 30, 2013." The company claims the reduction is necessary after an internal investigation revealed that a former employee "falsified the existence and amount of certain customer contracts."

If you purchased Merge common stock between February 19, 2013 and January 8, 2014 and suffered losses on that investment, you are encouraged to contact Holzer & Holzer, LLC and its attorney Marshall P. Dees, Esq. via email at mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832 regarding your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Holzer & Holzer, LLC
Marshall P. Dees, Esq., (888) 508-6832 (toll-free)
mdees@holzerlaw.com